LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC.

LABT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
424B3 Aug 17, 2026 PROSPECTUS SUPPLEMENT
SCHEDULE 13G Aug 14, 2026
10-Q Aug 14, 2026 QUARTERLY REPORT
DEFA14A Aug 10, 2026 DEFINITIVE ADDITIONAL MATERIALS
DEF 14A Aug 10, 2026 PROXY STATEMENT
SCHEDULE 13G Aug 6, 2026
PRE 14A Jul 30, 2026 PRELIMINARY PROXY STATEMENT
8-K Jul 15, 2026 CURRENT REPORT
SCHEDULE 13G Jun 23, 2026
424B3 Jun 22, 2026 PROSPECTUS SUPPLEMENT
424B3 Jun 22, 2026 PROSPECTUS SUPPLEMENT
8-K Jun 17, 2026 CURRENT REPORT
424B3 May 26, 2026 PROSPECTUS SUPPLEMENT
424B3 May 26, 2026 PROSPECTUS SUPPLEMENT
10-Q May 22, 2026 QUARTERLY REPORT
424B4 May 14, 2026 PROSPECTUS
EFFECT May 13, 2026
CORRESP May 12, 2026
UPLOAD May 8, 2026
4 May 6, 2026 4
3 May 6, 2026 3
3 May 1, 2026
3 May 1, 2026
3 May 1, 2026
3 May 1, 2026
← Newer Page 1 of 2 · 40 filings Older →